Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.Sweta Chekuri, Marc Carrier, Robert S Rosenson et al.|Bristol Research (University of Bristol)|2021Cited by 589
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19Ewan C. Goligher, Allen Cheng, Patrick R. Lawler et al.|JAMA|2023Cited by 98
Therapeutic Anticoagulation in Non-Critically Ill Patients with Covid-19Ryan Zarychanski, Patrick R. Lawler, Ewan C. Goligher et al.|medRxiv|2021Cited by 19
Effect of P2Y12 Inhibitors on Organ Support–Free Survival in Critically Ill Patients Hospitalized for COVID-19Jeffrey S. Berger, Matthew D. Neal, Lucy Z. Kornblith et al.|JAMA Network Open|2023Cited by 17
Prothrombotic antibodies targeting the spike protein's receptor-binding domain in severe COVID-19Wen Zhu, Renren Wen, Yongwei Zheng et al.|Blood|2024Cited by 5